Disease Spotlight: Prostate Cancer

Latest News

FDA Clears Updated MRI/Ultrasound Fusion System for Use in Focal Therapy of Prostate Cancer
FDA Clears Updated MRI/Ultrasound Fusion System for Use in Focal Therapy of Prostate Cancer

July 23rd 2025

Advanced annotation with the updated UroNav MRI/ultrasound fusion platform may facilitate enhanced precision and efficiency with focal therapies for prostate cancer.

Adjunctive AI Bolsters Lesion-Level PPVs for csPCa in International bpMRI Study
Adjunctive AI Bolsters Lesion-Level PPVs for csPCa in International bpMRI Study

July 17th 2025

Study: Adjunctive AI Provides Over 18 Percent Higher Lesion-Level Sensitivity on Prostate MRI
Study: Adjunctive AI Provides Over 18 Percent Higher Lesion-Level Sensitivity on Prostate MRI

July 15th 2025

Emerging Medication for mCRPC Gets FDA Fast Track Designation for Adjunctive Use with Radiation Therapy
Emerging Medication for mCRPC Gets FDA Fast Track Designation for Adjunctive Use with Radiation Therapy

July 10th 2025

CMS Issues Permanent HCPCS Code for the PSMA PET Prep Modality Gozellix
CMS Issues Permanent HCPCS Code for the PSMA PET Prep Modality Gozellix

July 9th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.